2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
[HTML][HTML] Editor's Choice–European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis
SK Kakkos, M Gohel, N Baekgaard… - European Journal of …, 2021 - ejves.com
2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …
Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report
Background Emerging evidence shows that severe coronavirus disease 2019 (COVID-19)
can be complicated by a significant coagulopathy, that likely manifests in the form of both …
can be complicated by a significant coagulopathy, that likely manifests in the form of both …
[HTML][HTML] Epidemiology and prevention of venous thromboembolism
Venous thromboembolism, that consists of the interrelated conditions deep-vein thrombosis
and pulmonary embolism, is an under-appreciated vascular disease. In Western regions …
and pulmonary embolism, is an under-appreciated vascular disease. In Western regions …
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
TL Ortel, I Neumann, W Ageno, R Beyth… - Blood …, 2020 - ashpublications.org
Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT)
and pulmonary embolism (PE), occurs in∼ 1 to 2 individuals per 1000 each year …
and pulmonary embolism (PE), occurs in∼ 1 to 2 individuals per 1000 each year …
Heart disease and stroke statistics—2019 update: a report from the American Heart Association
Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …
Institutes of Health and other government agencies, brings together in a single document the …
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The …
SV Konstantinides, G Meyer, C Becattini… - European heart …, 2020 - academic.oup.com
determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …
strategies. However, the ESC Guidelines do not override in any way whatsoever the …
Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial …
AM Young, A Marshall, J Thirlwall… - Journal of clinical …, 2018 - ascopubs.org
Purpose Venous thromboembolism (VTE) is common in patients with cancer. Long-term
daily subcutaneous low molecular weight heparin has been standard treatment for such …
daily subcutaneous low molecular weight heparin has been standard treatment for such …